Eman Elsenbawy

Prof. Eman Elsenbawy


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 February 2024 in Molecules
Verified
Journal Article
Open access
PDF file
EEEman Elsenbawy
Eman Elsenbawy
ZAZafer Saad Alshehri
Zafer Saad Alshehri
NBNouf Babteen
Nouf Babteen
AAAdel A.-H. Abdel-Rahman
Adel A.-H. Abdel-Rahman
MEMai A. El-Manawaty
Mai A. El-Manawaty
NHNasser A. Hassan
Nasser A. Hassan
A new series of thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines was designed and synthesized using readily available starting materials, specifically, β-enaminoester. Their cytotoxicity was screened against three cancer cell lines, namely, MCF-7, HCT-116, and PC-3. 2-(4-bromophenyl)triazole 10b and 2-(anthracen-9-yl)triazole 10e afforded excellent potency against MCF-7 cell lines (IC50 = 19.4 ± 0.22 and 14.5 ± 0.30 μM, respectively) compared with doxorubicin (IC50 = 40.0 ± 3.9 μM). The latter derivatives 10b and 10e were further subjected to in silico ADME and docking simulation studies against EGFR and PI3K and could serve as ideal leads for additional modification in the field of anticancer research.